Quick Takeaways
- GLAZER CAPITAL, LLC filed SCHEDULE 13G for DAY ONE BIOPHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share (DAWN).
- Disclosed ownership: 5.4%.
- Date of event: 12 Mar 2026.
GLAZER CAPITAL, LLC - 12 Mar 2026 SCHEDULE 13G Report for DAY ONE BIOPHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share (DAWN)
- Filing Manager
- GLAZER CAPITAL, LLC
- Reporting Manager
- Glazer Capital, LLC
- Symbol
- DAWN
- Shares outstanding
- 103,988,704 shares
- Disclosed Ownership
- 5,615,390 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 19 Mar 2026, 16:46:06 UTC
- Date of event
- 12 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"GLAZER CAPITAL, LLC disclosed 5.4% ownership in DAY ONE BIOPHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share (DAWN) on 12 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 Mar 2026, 16:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 5.4% | 5,615,390 | 0 | 5,615,390 | Paul J. Glazer | Paul J. Glazer, Managing Member | |
| Paul J. Glazer | 5.4% | 5,615,390 | 0 | 5,615,390 | Paul J. Glazer | Paul J. Glazer |